Lead WP7a:
Kirsteen Donaldson, FPM, UK
. Co-Lead: Ruth Hargreaves,
Pfizer Ltd., UK
Ingrid Klingmann, EFGCP
WP 7 a.: Leading the Examination Process
Objectives
To conceive, pilot and implement a standard examination concept with intra-examination and inter-examination controls (years and sites) (TF 1)
To enhance the knowledge base of professionals involved in the integrated development of drugs through establishing an exemplary and consistent examination standard across the EU in the discipline
To define standards in dealing with ethical issue for the entire PharmaTrain programme (TF 7.2 and para 5).